166 related articles for article (PubMed ID: 25745545)
1. Refractory thrombocytopenia and neutropenia: a diagnostic challenge.
Gyan E; Dreyfus F; Fenaux P
Mediterr J Hematol Infect Dis; 2015; 7(1):e2015018. PubMed ID: 25745545
[TBL] [Abstract][Full Text] [Related]
2. Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients.
Breccia M; Latagliata R; Cannella L; Carmosino I; Santopietro M; Loglisci G; Federico V; Alimena G
Leuk Lymphoma; 2010 May; 51(5):783-8. PubMed ID: 20302387
[TBL] [Abstract][Full Text] [Related]
3. Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Font P; Loscertales J; Soto C; Ricard P; Novas CM; Martín-Clavero E; López-Rubio M; Garcia-Alonso L; Callejas M; Bermejo A; Benavente C; Ballesteros M; Cedena T; Calbacho M; Urbina R; Villarrubia J; Gil S; Bellón JM; Diez-Martin JL; Villegas A
Ann Hematol; 2015 Apr; 94(4):565-73. PubMed ID: 25387664
[TBL] [Abstract][Full Text] [Related]
4. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
5. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
6. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
7. Refractory Thrombocytopenia with Multilineage Dysplasia: A Rare Type of Myelodysplastic Syndrome.
Demırkan F; Özsan GH; Özcan MA; Vural F; Öztop İ; Yüksel E; Ündar B
Turk J Haematol; 2003 Mar; 20(1):25-30. PubMed ID: 27265331
[TBL] [Abstract][Full Text] [Related]
8. Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification.
Font P; Loscertales J; Benavente C; Bermejo A; Callejas M; Garcia-Alonso L; Garcia-Marcilla A; Gil S; Lopez-Rubio M; Martin E; Muñoz C; Ricard P; Soto C; Balsalobre P; Villegas A
Ann Hematol; 2013 Jan; 92(1):19-24. PubMed ID: 22948274
[TBL] [Abstract][Full Text] [Related]
9. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification.
Verburgh E; Achten R; Louw VJ; Brusselmans C; Delforge M; Boogaerts M; Hagemeijer A; Vandenberghe P; Verhoef G
Leukemia; 2007 Apr; 21(4):668-77. PubMed ID: 17301818
[TBL] [Abstract][Full Text] [Related]
10. [Myelodysplastic syndrome classification].
Ghariani I; Braham N; Hassine M; Kortas M
Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
[TBL] [Abstract][Full Text] [Related]
11. Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure.
Irons RD; Gross SA; Le A; Wang XQ; Chen Y; Ryder J; Schnatter AR
Chem Biol Interact; 2010 Mar; 184(1-2):30-8. PubMed ID: 19941839
[TBL] [Abstract][Full Text] [Related]
12. Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms.
Bennett JM
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):607-609. PubMed ID: 27693133
[TBL] [Abstract][Full Text] [Related]
13. [Myelodysplastic syndrome with early presentation of refractory monolineage cytopenia-with report of 13 cases].
Cheng SC; Yu YF; Li SL; Wang YZ; Ge CW; Feng SF; Liu HL; Liang WT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):303-6. PubMed ID: 12513762
[TBL] [Abstract][Full Text] [Related]
14. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
15. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
Singh ZN; Post GR; Kiwan E; Maddox AM
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
[TBL] [Abstract][Full Text] [Related]
16. Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts.
Maassen A; Strupp C; Giagounidis A; Kuendgen A; Nachtkamp K; Hildebrandt B; Gattermann N; Aul C; Haas R; Germing U
Leuk Res; 2013 Jan; 37(1):64-70. PubMed ID: 23122806
[TBL] [Abstract][Full Text] [Related]
17. Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia.
Iwafuchi H; Ito M
Histopathology; 2019 Jan; 74(2):239-247. PubMed ID: 30062702
[TBL] [Abstract][Full Text] [Related]
18. [Myelodysplastic syndromes].
Garandeau C; Pautas E; Andreux M; Andreux J; Gaussem P; Siguret V
Ann Biol Clin (Paris); 2000; 58(4):405-16. PubMed ID: 10932040
[TBL] [Abstract][Full Text] [Related]
19. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
20. Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood.
Erlacher M; Strahm B
Front Pediatr; 2015; 3():64. PubMed ID: 26217651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
